A Abdel Razek1, A Mossad, M Ghonim. 1. Department of Diagnostic Radiology, Mansoura Faculty of Medicine, Mansoura, Egypt. arazek@mans.eun.eg
Abstract
PURPOSE: This study was done to assess the role of diffusion-weighted magnetic resonance (MR) imaging in assessing malignant versus benign skull lesions. MATERIALS AND METHODS: A retrospective analysis was undertaken of 45 patients (26 male, 19 female; age range 14-68 years, mean age 39 years) with skull-base lesions. Diffusion-weighted MR images were acquired with a b-factor of 500 and 1,000 s/mm(2) using single-shot echoplanar imaging. Apparent diffusion coefficient (ADC) maps were reconstructed, and the ADC value of the lesion was calculated. RESULTS: The mean ADC value of malignant tumours was (1.002 ± 0.21) × 10(-3) mm(2)/s and that of benign tumours was (1.63 ± 0.29) × 10(-3) mm(2)/s. There was a statistically significant difference (p=0.001) in the ADC value of malignant skull-base tumours versus benign lesions. Selection of (1.3) × 10(-3)mm(2)/s as a threshold value of ADC for differentiating benign from malignant tumours yielded the best result, with an accuracy of 94%, sensitivity of 94%, specificity of 93%, positive predictive value of 93%, negative predictive value of 94% and area under the curve of 0.932. CONCLUSIONS: We conclude that diffusion-weighted MR imaging is a promising, noninvasive approach that can be used to characterise skull-base lesions in that it can help differentiate malignant tumours from benign lesions and evaluate the pathological grading of malignant tumours.
PURPOSE: This study was done to assess the role of diffusion-weighted magnetic resonance (MR) imaging in assessing malignant versus benign skull lesions. MATERIALS AND METHODS: A retrospective analysis was undertaken of 45 patients (26 male, 19 female; age range 14-68 years, mean age 39 years) with skull-base lesions. Diffusion-weighted MR images were acquired with a b-factor of 500 and 1,000 s/mm(2) using single-shot echoplanar imaging. Apparent diffusion coefficient (ADC) maps were reconstructed, and the ADC value of the lesion was calculated. RESULTS: The mean ADC value of malignant tumours was (1.002 ± 0.21) × 10(-3) mm(2)/s and that of benign tumours was (1.63 ± 0.29) × 10(-3) mm(2)/s. There was a statistically significant difference (p=0.001) in the ADC value of malignant skull-base tumours versus benign lesions. Selection of (1.3) × 10(-3)mm(2)/s as a threshold value of ADC for differentiating benign from malignant tumours yielded the best result, with an accuracy of 94%, sensitivity of 94%, specificity of 93%, positive predictive value of 93%, negative predictive value of 94% and area under the curve of 0.932. CONCLUSIONS: We conclude that diffusion-weighted MR imaging is a promising, noninvasive approach that can be used to characterise skull-base lesions in that it can help differentiate malignant tumours from benign lesions and evaluate the pathological grading of malignant tumours.
Authors: J Wang; S Takashima; F Takayama; S Kawakami; A Saito; T Matsushita; M Momose; T Ishiyama Journal: Radiology Date: 2001-09 Impact factor: 11.105
Authors: C R Habermann; C Arndt; J Graessner; L Diestel; K U Petersen; F Reitmeier; J O Ussmueller; G Adam; M Jaehne Journal: AJNR Am J Neuroradiol Date: 2009-01-08 Impact factor: 3.825
Authors: F Pasquinelli; G Belli; L N Mazzoni; F Regini; C Nardi; L Grazioli; A L Zignego; A Linda Zignego; S Colagrande Journal: Radiol Med Date: 2011-10-21 Impact factor: 3.469